Genetics in Headache and Neurogenic Pain
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Neurogenomics".
Deadline for manuscript submissions: 25 February 2026 | Viewed by 99
Special Issue Editors
Interests: headache disorders; RNAseq in headache; migraine; neuropathic pain; clinical trials; biomarkers; gene and cell therapy
Special Issue Information
Dear Colleagues,
This Special Issue seeks proposals that examine the genetic underpinnings of headache disorders and neurogenic pain, reflecting the latest advancements in genomic research. It welcomes high-impact contributions that elucidate molecular mechanisms, polygenic risk scores, epigenetic modifications, and novel therapeutic targets for conditions such as migraine, cluster headache, and neuropathic pain. Submissions should explore cutting-edge topics, including single-cell genomics, CRISPR-based functional studies, gene–environment interactions, or precision medicine strategies. This Special Issue aims to advance translational research and foster interdisciplinary collaboration to address these debilitating neurological conditions. Join us in shaping the future of genetic research in pain management.
Dr. Yohannes W. Woldeamanuel
Dr. Xianghong Arakaki
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetics
- headache
- neurogenic pain
- migraine
- genomics
- epigenetics
- polygenic risk
- biomarkers
- precision medicine
- CRISPR
- neuropathic pain
- gene–environment interactions
- translational research
- molecular mechanisms
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
